← Back to Search

Emollient

Metaderm for Psoriasis

Phase 4

Waitlist Available

Led By Boni Elewski, MD

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to week 12

Awards & highlights

Study Summary

This trial is testing a natural cream to see if it is safe and effective for treating psoriasis.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to week 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to week 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Efficacy as Measured by the Mean Percentage Change in the Product of Static Physician Global Assessment (sPGA) and Body Surface Area (BSA).

Secondary outcome measures

Efficacy as Measured by the Percentage Change in the DLQI. (Dermatology Quality of Life Index).

Trial Design

2Treatment groups

Experimental Treatment

Group I: Systemic Therapy + Herbal Anti-Inflammatory Treatment (HAT1)Experimental Treatment1 Intervention

Patients who received HAT1 and were on systemic treatment at time of enrollment. Metaderm cream will be applied topically twice a day to all active lesions. The metaderm scalp spray will be applied daily to the affected areas on the scalp.

Group II: Nonsystemic Therapy + Herbal Anti-Inflammatory Treatment (HAT1)Experimental Treatment1 Intervention

Patients who received HAT1 and were not on systemic treatment at time of enrollment. Metaderm cream will be applied topically twice a day to all active lesions. The metaderm scalp spray will be applied daily to the affected areas on the scalp.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Metaderm

2018

Completed Phase 4

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor

1,589 Previous Clinical Trials

2,280,343 Total Patients Enrolled

7 Trials studying Psoriasis

40,671 Patients Enrolled for Psoriasis

Boni Elewski, MDPrincipal InvestigatorUniversity of Alabama at Birmingham

4 Previous Clinical Trials

512 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent can Metaderm be detrimental to individuals' wellbeing?

"There is extensive data available to demonstrate safety, leading Metaderm to receive a score of 3."

Answered by AI

Is the recruitment process for this clinical trial currently ongoing?

"According to the clinicaltrials.gov database, this particular study is not presently seeking participants as it was last updated on September 1st 2022. However, there are 167 other medical trials currently enrolling patients across a variety of conditions."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis

Boni Elewski 2018. "Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03597620.